Long-Term Follow-Up Of Anti-Cd19 Car T-Cell Therapy For B-Cell Lymphoma And Chronic Lymphocytic Leukemia.

Kathryn Cappell,Richard Mark Sherry,James C. Yang,Stephanie L. Goff,Danielle Vanasse,Lori McIntyre,Steven A. Rosenberg,James N. Kochenderfer

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 7|浏览21

暂无评分

摘要

3012Background: T cells expressing anti-CD19 chimeric antigen receptors (CARs) can cause complete remissions of relapsed lymphoma. We conducted the first clinical trial of anti-CD19 CAR T cells to ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要